Current paradigms about chemokines as therapeutic targets

被引：7

作者：

Anders, HJ ^{[1
]}

Vielhauer, V ^{[1
]}

Schlöndorff, D ^{[1
]}

机构：

[1] Univ Munich, Anders Med Poliklin, Nephrol Ctr, D-80336 Munich, Germany

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 2004年 / 19卷 / 12期

关键词：

D O I：

10.1093/ndt/gfh497

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

引用

页码：2948 / 2951

页数：4

共 33 条

[1] Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice [J].

Anders, HJ ;

Belemezova, E ;

Eis, V ;

Segerer, S ;

Vielhauer, V ;

De Lema, GP ;

Kretzler, M ;

Cohen, CD ;

Frink, M ;

Horuk, R ;

Hudkins, KL ;

Alpers, CE ;

Mampaso, F ;

Schlöndorff, D .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (06) :1504-1513

[2] CC chemokine ligand 5/RANTES chemokine antagonists aggravate glomerulonephritis despite reduction of glomerular leukocyte infiltration [J].

Anders, HJ ;

Frink, M ;

Linde, Y ;

Banas, B ;

Wörnle, M ;

Cohen, CD ;

Vielhauer, V ;

Nelson, PJ ;

Gröne, HJ ;

Schlöndorff, D .

JOURNAL OF IMMUNOLOGY, 2003, 170 (11) :5658-5666

[3] Chemokines and chemokine receptors are involved in the resolution or progression of renal disease [J].

Anders, HJ ;

Vielhauer, V ;

Schlöndorff, D .

KIDNEY INTERNATIONAL, 2003, 63 (02) :401-415

[4] Bacterial CpG-DNA aggravates immune complex glomerulonephritis:: Role of TLR9-mediated expression of chemokines and chemokine receptors [J].

Anders, HJ ;

Banas, B ;

Linde, Y ;

Weller, L ;

Cohen, CD ;

Kretzler, M ;

Martin, S ;

Vielhauer, V ;

Schlöndorff, D ;

Gröne, HJ .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (02) :317-326

[5] A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation [J].

Anders, HJ ;

Vielhauer, V ;

Frink, M ;

Linde, Y ;

Cohen, CD ;

Blattner, SM ;

Kretzler, M ;

Strutz, F ;

Mack, M ;

Gröne, HJ ;

Onuffer, J ;

Horuk, R ;

Nelson, PJ ;

Schlöndorff, D .

JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (02) :251-259

[6]

Anders HJ, 2001, J AM SOC NEPHROL, V12, P919, DOI 10.1681/ASN.V125919

[7] Roles of SLC/CCL21 and CCR7 in human kidney for mesangial proliferation, migration, apoptosis, and tissue homeostasis [J].

Banas, B ;

Wörnle, M ;

Berger, T ;

Nelson, PJ ;

Cohen, CD ;

Kretzler, M ;

Pfirstinger, J ;

Mack, M ;

Lipp, M ;

Gröne, HJ ;

Schlöndorff, D .

JOURNAL OF IMMUNOLOGY, 2002, 168 (09) :4301-4307

[8] Dual role of CCR2 during initiation and progression of collagen-induced arthritis:: Evidence for regulatory activity of CCR2+ T cells [J].

Brühl, H ;

Cihak, J ;

Schneider, MA ;

Plachy, J ;

Rupp, T ;

Wenzel, I ;

Shakarami, M ;

Milz, S ;

Ellwart, JW ;

Stangassinger, M ;

Schlöndorff, D ;

Mack, M .

JOURNAL OF IMMUNOLOGY, 2004, 172 (02) :890-898

[9] Chemokine receptor CCR1 but not CCR5 mediates leukocyte recruitment and subsequent renal fibrosis after unilateral ureteral obstruction [J].

Eis, V ;

Luckow, B ;

Vielhauer, V ;

Siveke, JT ;

Linde, Y ;

Segerer, S ;

de Lema, GP ;

Cohen, CD ;

Kretzler, M ;

Mack, M ;

Horuk, R ;

Murphy, PM ;

Gao, JL ;

Hudkins, KL ;

Alpers, CE ;

Gröne, HJ ;

Schlöndorff, D ;

Anders, HJ .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (02) :337-347

[10] CC chemokine receptor 5 and renal-transplant survival [J].

Fischereder, M ;

Luckow, B ;

Hocher, B ;

Wüthrich, RP ;

Rothenpieler, U ;

Schneeberger, H ;

Panzer, U ;

Stahl, RAK ;

Hauser, IA ;

Budde, K ;

Neumayer, HH ;

Krämer, BK ;

Land, W ;

Schlöndorff, D .

LANCET, 2001, 357 (9270) :1758-1761

← 1 2 3 4 →